BDBM474105 US10858364, formula (I)

SMILES CC#CC(=O)NCCCC(=O)c1nc(-c2ccc(cc2)C(=O)Nc2ccccn2)c2c(N)nccn12

InChI Key InChIKey=XZAATUBTUPPERZ-UHFFFAOYSA-N

Data  10 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 474105   

TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

US Patent
LigandPNGBDBM474105(US10858364, formula (I))
Affinity DataIC50: 5nMAssay Description:TBDBTK enzyme (His-BTK (Millipore catalog #14-552)), is diluted to 0.4 U/mL in KR buffer (10 mM Tris-HCl, 10 mM MgCl2, 0.01% Tween-20, 0.05% NaN3, 1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
US Patent

TargetCytoplasmic tyrosine-protein kinase BMX(Human)
Acerta Pharma

US Patent
LigandPNGBDBM474105(US10858364, formula (I))
Affinity DataIC50: 15nMAssay Description:BMX, TXK, EGFR, ERBB2, ERBB4, JAK3, BLK kinase activity was measured using the Z′-LYTE assay at Thermo Fisher. A 10-point dose response (final ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-4(Human)
Acerta Pharma

US Patent
LigandPNGBDBM474105(US10858364, formula (I))
Affinity DataIC50: 343nMAssay Description:BMX, TXK, EGFR, ERBB2, ERBB4, JAK3, BLK kinase activity was measured using the Z′-LYTE assay at Thermo Fisher. A 10-point dose response (final ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Tec(Human)
Acerta Pharma

US Patent
LigandPNGBDBM474105(US10858364, formula (I))
Affinity DataIC50: 345nMAssay Description:TEC enzyme (LifeTech # PV3269) and Eu-anti-HIS antibody (Invitrogen # PV5596) are mixed and diluted in kinase buffer (50 mM Hepes pH 7.5+10 mM MgCl2+...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Acerta Pharma

US Patent
LigandPNGBDBM474105(US10858364, formula (I))
Affinity DataIC50: 552nMAssay Description:BMX, TXK, EGFR, ERBB2, ERBB4, JAK3, BLK kinase activity was measured using the Z′-LYTE assay at Thermo Fisher. A 10-point dose response (final ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Acerta Pharma

US Patent
LigandPNGBDBM474105(US10858364, formula (I))
Affinity DataIC50: 567nMAssay Description:BMX, TXK, EGFR, ERBB2, ERBB4, JAK3, BLK kinase activity was measured using the Z′-LYTE assay at Thermo Fisher. A 10-point dose response (final ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Blk(Human)
Acerta Pharma

US Patent
LigandPNGBDBM474105(US10858364, formula (I))
Affinity DataIC50: 6.17E+3nMAssay Description:BMX, TXK, EGFR, ERBB2, ERBB4, JAK3, BLK kinase activity was measured using the Z′-LYTE assay at Thermo Fisher. A 10-point dose response (final ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase ITK/TSK(Human)
Acerta Pharma

US Patent
LigandPNGBDBM474105(US10858364, formula (I))
Affinity DataIC50: 1.00E+4nMAssay Description:TBITK enzyme (Millipore #14-660M) is diluted to 0.2 U/mL in KR buffer (10 mM Tris-HCl, 10 mM MgCl2, 0.01% Tween-20, 0.1% NaN3, 1 mM DTT, 2 mM MnCl2, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Acerta Pharma

US Patent
LigandPNGBDBM474105(US10858364, formula (I))
Affinity DataIC50: 1.00E+4nMAssay Description:BMX, TXK, EGFR, ERBB2, ERBB4, JAK3, BLK kinase activity was measured using the Z′-LYTE assay at Thermo Fisher. A 10-point dose response (final ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Acerta Pharma

US Patent
LigandPNGBDBM474105(US10858364, formula (I))
Affinity DataIC50: 1.00E+4nMAssay Description:BMX, TXK, EGFR, ERBB2, ERBB4, JAK3, BLK kinase activity was measured using the Z′-LYTE assay at Thermo Fisher. A 10-point dose response (final ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
US Patent